All Relations between Alzheimer Disease and Dementia

Publication Sentence Publish Date Extraction Date Species
Kara Dassel, Rebecca L Utz, Ana Sanchez-Birkhead, Sara Carbajal-Salisbury, Jeannette Villalta, Moroni Cajavilca, Lauren Solkowski, Nancy Aruscavage, Kathie Supiano, Eli Iaco. Health Disparities in Advance Care Planning: Development of a Spanish-Language LEAD Guide (Life-Planning in Early Alzheimer's and Other Dementias). Health equity. vol 7. issue 1. 2023-08-28. PMID:37638115. the lead (life-planning in early alzheimer's and other dementias) guide is an advance care planning (acp) tool for use within the context of dementia. 2023-08-28 2023-09-07 Not clear
Jingxuan Wang, Peter Buto, Sarah F Ackley, Lindsay C Kobayashi, Rebecca E Graff, Scott C Zimmerman, Eleanor Hayes-Larson, Elizabeth Rose Mayeda, Stephen B Asiimwe, Camilla Calmasini, M Maria Glymou. Association between cancer and dementia risk in the UK Biobank: evidence of diagnostic bias. European journal of epidemiology. 2023-08-27. PMID:37634228. we used cox models to evaluate associations of prevalent and incident cancer with all-cause dementia, alzheimer's disease (ad), and vascular dementia. 2023-08-27 2023-09-07 human
Javier Avendaño-Godoy, Arnoldo Miranda, Sigrid Mennickent, Carolina Gómez-Gaet. Intramuscularly Administered PLGA Microparticles for Sustained Release of Rivastigmine: In Vitro, In Vivo and Histological Evaluation. Journal of pharmaceutical sciences. 2023-08-26. PMID:37595752. rivastigmine is an acetylcholinesterase (ache) and butyrylcholinesterase (bche) inhibitor drug approved by the us food and drug administration (fda) for the treatment of mild to moderate dementia of alzheimer's type. 2023-08-26 2023-09-07 rat
Timothy J Baumgartner, Zahra Haghighijoo, Nana A Goode, Nolan M Dvorak, Parsa Arman, Fernanda Laezz. Voltage-Gated Na Life (Basel, Switzerland). vol 13. issue 8. 2023-08-26. PMID:37629512. voltage-gated na alzheimer's disease (ad) is the most common cause of dementia and is classically characterized by two major histopathological abnormalities: extracellular plaques composed of amyloid beta (aβ) and intracellular hyperphosphorylated tau. 2023-08-26 2023-09-07 Not clear
Ming-Ching Lin, Yu-Chun Chi. Application of the Semantic Fluency Test in the Screening of Mandarin-Chinese-Speaking Older Adults with Mild Dementia of the Alzheimer Type. Behavioral sciences (Basel, Switzerland). vol 13. issue 8. 2023-08-25. PMID:37622775. application of the semantic fluency test in the screening of mandarin-chinese-speaking older adults with mild dementia of the alzheimer type. 2023-08-25 2023-09-07 human
Ming-Ching Lin, Yu-Chun Chi. Application of the Semantic Fluency Test in the Screening of Mandarin-Chinese-Speaking Older Adults with Mild Dementia of the Alzheimer Type. Behavioral sciences (Basel, Switzerland). vol 13. issue 8. 2023-08-25. PMID:37622775. semantic fluency tests have been widely used as a screening test for dementia of alzheimer type. 2023-08-25 2023-09-07 human
Ming-Ching Lin, Yu-Chun Chi. Application of the Semantic Fluency Test in the Screening of Mandarin-Chinese-Speaking Older Adults with Mild Dementia of the Alzheimer Type. Behavioral sciences (Basel, Switzerland). vol 13. issue 8. 2023-08-25. PMID:37622775. this study aimed to explore the feasibility of using different semantic fluency test categories to distinguish between older adults without cognitive impairments and those with dementia of alzheimer type in taiwan. 2023-08-25 2023-09-07 human
Ming-Ching Lin, Yu-Chun Chi. Application of the Semantic Fluency Test in the Screening of Mandarin-Chinese-Speaking Older Adults with Mild Dementia of the Alzheimer Type. Behavioral sciences (Basel, Switzerland). vol 13. issue 8. 2023-08-25. PMID:37622775. furthermore, this study proposed optimal cutoff points and calculated the auc for various test durations (i.e., 30 s, 45 s and 60 s) and semantic categories in the semantic fluency test, which may serve as a reference that would help clinical personnel distinguish between older adults without cognitive impairments and those with dementia of alzheimer type in taiwan. 2023-08-25 2023-09-07 human
Mariana Mendes, Érica Correia, Anabela Vitorino, José Rodrigues, Luís Cid, Teresa Bento, Raul Antunes, Diogo Monteiro, Nuno Cout. Effects of Exercise on Quality of Life in Subjects with Alzheimer's Disease: Systematic Review with Meta-Analysis of Randomized Clinical Trials. Sports (Basel, Switzerland). vol 11. issue 8. 2023-08-25. PMID:37624129. alzheimer's disease is a type of dementia that progressively affects memory, thinking, and behavior. 2023-08-25 2023-09-07 human
Claudio Babiloni, Susanna Lopez, Giuseppe Noce, Raffaele Ferri, Simonetta Panerai, Valentina Catania, Andrea Soricelli, Marco Salvatore, Flavio Nobili, Dario Arnaldi, Francesco Famà, Federico Massa, Carla Buttinelli, Franco Giubilei, Fabrizio Stocchi, Laura Vacca, Moira Marizzoni, Fabrizia D'Antonio, Giuseppe Bruno, Carlo De Lena, Bahar Güntekin, Ebru Yıldırım, Lutfu Hanoğlu, Görsev Yener, Deniz Yerlikaya, John Paul Taylor, Julia Schumacher, Ian McKeith, Laura Bonanni, Patrizia Pantano, Claudia Piervincenzi, Nikolaos Petsas, Giovanni B Frisoni, Claudio Del Percio, Filippo Carducc. Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to Alzheimer's disease. Cerebral cortex (New York, N.Y. : 1991). 2023-08-24. PMID:37615301. relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to alzheimer's disease. 2023-08-24 2023-09-07 human
Soudabeh Naderi, Fereshteh Motamedi, Hamid Gholami Pourbadie, Shahrbanoo Rafiei, Fariba Khodagholi, Nima Naderi, Mahyar Janahmad. Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca Neurochemical research. 2023-08-24. PMID:37615884. neuroprotective effects of ferrostatin and necrostatin against entorhinal amyloidopathy-induced electrophysiological alterations mediated by voltage-gated ca alzheimer's disease (ad) is a progressive neurodegenerative disease that is the main form of dementia. 2023-08-24 2023-09-07 Not clear
Qi Zhang, Chunqiu Fan, Luyao Wang, Taoran Li, Min Wang, Ying Han, Jiehui Jian. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of GeroScience. 2023-08-23. PMID:37610594. glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to alzheimer's disease: an exploratory study of amyloid-β (aβ) and tau are important biomarkers to predict the progression of cognitively unimpaired (cu) to dementia due to alzheimer's disease (ad), according to the diagnosis framework from the us national institute on aging and the alzheimer's association (nia-aa). 2023-08-23 2023-09-07 human
Shiloh L Echevarria-Cooper, Emily H Ho, Richard C Gershon, Sandra Weintraub, Thorsten Kahn. Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023-08-21. PMID:37603693. olfactory decline is associated with cognitive decline in aging, amnestic mild cognitive impairment (amci), and amnestic dementia associated with alzheimer's disease neuropathology (add). 2023-08-21 2023-09-07 Not clear
Kolade Oluwagbemigun, Andrea Anesi, Urska Vrhovsek, Fulvio Mattivi, Pamela Martino Adami, Michael Pentzek, Martin Scherer, Steffi G Riedel-Heller, Siegfried Weyerer, Horst Bickel, Birgitt Wiese, Matthias Schmid, John F Cryan, Alfredo Ramirez, Michael Wagner, Ute Nöthling. An Investigation into the Relationship of Circulating Gut Microbiome Molecules and Inflammatory Markers with the Risk of Incident Dementia in Later Life. Molecular neurobiology. 2023-08-21. PMID:37605096. plasma levels of 19 selected gut microbiome molecules comprising lipopolysaccharide, short-chain fatty acids, and indole-containing tryptophan metabolites as well as four inflammatory markers measured at baseline were linked to incident all-cause (acd) and alzheimer's disease dementia (ad) in binary outcomes and time-to-dementia analyses. 2023-08-21 2023-09-07 Not clear
Asmus Vogel, Clara Mellergaard, Kristian Steen Frederikse. Different language profiles on neuropsychological tests in dementia with Lewy bodies and Alzheimer's disease. Applied neuropsychology. Adult. 2023-08-18. PMID:37595289. dementia with lewy bodies (dlb) and alzheimer's disease (ad) may lead to different cognitive profiles. 2023-08-18 2023-10-07 Not clear
Bernadette Boden-Albala, Vida Rebello, Emily Drum, Desiree Gutierrez, Wally R Smith, Rachel A Whitmer, Derek M Griffit. Use of Community-Engaged Research Approaches in Clinical Interventions for Neurologic Disorders in the United States: A Scoping Review and Future Directions for Improving Health Equity Research. Neurology. vol 101. issue 7 Supplement 1. 2023-08-14. PMID:37580148. evidence suggests a significant prevalence of race and ethnic disparities in the united states among people with neurologic conditions including stroke, alzheimer disease and related dementia (adrd), parkinson disease (pd), epilepsy, spinal cord injury (sci), and traumatic brain injury (tbi). 2023-08-14 2023-09-07 Not clear
Noah J Graves, Yann Gambin, Emma Siereck. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies. International journal of molecular sciences. vol 24. issue 15. 2023-08-12. PMID:37569510. in addition to pd, αsyn pathological aggregation is also detected in atypical parkinsonism, including dementia with lewy bodies (dlb), multiple system atrophy (msa), as well as neurodegeneration with brain iron accumulation, some cases of traumatic brain injuries, and variants of alzheimer's disease. 2023-08-12 2023-08-16 Not clear
Ji-Yun Cheng, Yue-Ting Deng, Jin-Tai Y. The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study. Journal of neurochemistry. 2023-08-11. PMID:37565992. the potential causalities between nine amino acids (glutamine [glu], leucine [leu], isoleucine [ile], phenylalanine [phe], valine [val], alanine [ala], tyrosine [tyr], histidine [his], and glycine [gly]) and six neurodegenerative disorders (alzheimer's disease [ad], parkinson's disease [pd], multiple sclerosis [ms], frontotemporal dementia [ftd], lewy body dementia [dlb], amyotrophic lateral sclerosis [als]) were explored in this study. 2023-08-11 2023-08-16 Not clear
Priyanka Mishra, Alexander Silva, Jay Sharma, Jacqueline Nguyen, Donald P Pizzo, Denise Hinz, Debashis Sahoo, Stephanie Cherqu. Rescue of Alzheimer's disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells. Cell reports. vol 42. issue 8. 2023-08-10. PMID:37561625. alzheimer's disease (ad) is the most prevalent cause of dementia; microglia have been implicated in ad pathogenesis, but their role is still matter of debate. 2023-08-10 2023-08-16 mouse
Michael B Prough, Andrew Zaman, Laura J Caywood, Jason E Clouse, Sharlene D Herington, Susan H Slifer, Daniel A Dorfsman, Larry A Adams, Reneé A Laux, Yeunjoo E Song, Audrey Lynn, Denise Fuzzell, Sarada L Fuzzell, Sherri D Miller, Kristy Miskimen, Leighanne R Main, Michael D Osterman, Paula Ogrocki, Alan J Lerner, Jeffery M Vance, Jonathan L Haines, William K Scott, Margaret Pericak-Vance, Michael L Cuccar. Visuospatial and Verbal Memory Differences in Amish Individuals with Alzheimer Disease and Related Dementias. Alzheimer disease and associated disorders. 2023-08-10. PMID:37561946. visuospatial and verbal memory differences in amish individuals with alzheimer disease and related dementias. 2023-08-10 2023-08-16 Not clear